- Home
- ROL vs BNTX Comparison
ROL vs BNTX Comparison
Compare ROL & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROL
- BNTX
- Stock Information
- Founded
- ROL 1948
- BNTX 2008
- Country
- ROL United States
- BNTX Germany
- Employees
- ROL N/A
- BNTX N/A
- Industry
- ROL Diversified Commercial Services
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ROL Finance
- BNTX Health Care
- Exchange
- ROL Nasdaq
- BNTX Nasdaq
- Market Cap
- ROL 27.6B
- BNTX 26.4B
- IPO Year
- ROL N/A
- BNTX 2019
- Fundamental
- Price
- ROL $55.04
- BNTX $110.65
- Analyst Decision
- ROL Buy
- BNTX Strong Buy
- Analyst Count
- ROL 8
- BNTX 18
- Target Price
- ROL $59.50
- BNTX $141.60
- AVG Volume (30 Days)
- ROL 1.6M
- BNTX 627.8K
- Earning Date
- ROL 07-23-2025
- BNTX 08-04-2025
- Dividend Yield
- ROL 1.20%
- BNTX N/A
- EPS Growth
- ROL 9.41
- BNTX N/A
- EPS
- ROL 0.99
- BNTX N/A
- Revenue
- ROL $3,462,863,000.00
- BNTX $2,968,331,171.00
- Revenue This Year
- ROL $11.84
- BNTX N/A
- Revenue Next Year
- ROL $8.58
- BNTX $8.61
- P/E Ratio
- ROL $56.57
- BNTX N/A
- Revenue Growth
- ROL 9.46
- BNTX 0.61
- 52 Week Low
- ROL $45.34
- BNTX $76.53
- 52 Week High
- ROL $58.65
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- ROL 40.98
- BNTX 57.02
- Support Level
- ROL $54.85
- BNTX $105.35
- Resistance Level
- ROL $55.91
- BNTX $114.00
- Average True Range (ATR)
- ROL 0.97
- BNTX 2.56
- MACD
- ROL -0.12
- BNTX 0.19
- Stochastic Oscillator
- ROL 7.10
- BNTX 70.69
About ROL Rollins Inc.
Rollins is a global leader in route-based pest control services, with operations primarily in the United States, as well as in North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US, which boasts near national coverage, and in Canada. Residential pest and termite prevention dominates the services provided by Rollins, owing to the group's ongoing focus on the US and Canadian markets.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.